Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,604 | 100,333 | 64,332 | 75,867 | 85,723 |
| Marketable Securities | 24,829 | 32,535 | 28,392 | 34,847 | 38,433 |
| Receivables | 2,020 | 3,254 | 50,807 | 834 | 889 |
| Other current assets | 0 | 0 | 2,458 | 262 | 0 |
| TOTAL | $130,613 | $140,533 | $147,600 | $112,791 | $126,690 |
| Non-Current Assets | |||||
| PPE Net | 1,836 | 1,432 | 1,252 | 1,432 | 1,614 |
| Other Non-Current Assets | 2,832 | 1,460 | 1,037 | 1,083 | 1,204 |
| TOTAL | $4,668 | $2,892 | $2,289 | $2,515 | $2,818 |
| Total Assets | $135,281 | $143,425 | $149,889 | $115,306 | $129,508 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,853 | 4,640 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,167 | 4,010 | 7,799 | 2,930 | 2,656 |
| Accrued Expenses | 10,027 | 8,193 | 5,444 | 4,257 | 2,992 |
| Other current liabilities | 4,829 | 4,732 | 4,355 | 9,251 | 9,870 |
| TOTAL | $23,575 | $21,954 | $17,859 | $16,726 | $16,338 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,173 | 4,329 | 4,509 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 485 |
| TOTAL | $36,430 | $35,431 | $39,372 | $4,542 | $4,760 |
| Total Liabilities | $60,005 | $57,385 | $57,231 | $21,268 | $21,099 |
| Shareholders' Equity | |||||
| Common Shares | 3,715 | 3,715 | 3,715 | 3,656 | 3,653 |
| Retained earnings | -122,009 | N/A | -93,463 | -94,460 | -89,288 |
| Other shareholders' equity | -854 | -4,030 | -12,018 | -7,440 | 1,774 |
| TOTAL | $75,276 | $86,040 | $92,658 | $94,038 | $108,409 |
| Total Liabilities And Equity | $135,281 | $143,425 | $149,889 | $115,306 | $129,508 |